Unlike TET2 and DNMT3A mutations that occur at the haematopoietic stem cell level, both RHOA and IDH2 mutations are restricted to the neoplastic T‐cell clone in AITL and PTCL‐TFH 7, 16, 21, 22. This evidence concerns the gene DNMT3A and angioimmunoblastic T-cell lymphoma.